“…In addition, some of the miRNAs identified using our analysis including miR‐450b‐5p, miR‐199s, and miR‐361‐5p, whose expressions were upregulated in all three categories, may act as an oncomiR or a tumor suppressor in certain types of tumors although their functions are ambiguous in pediatric HCC, implying a contextual role of these miRNAs. 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 Given the relatively small number of samples analyzed in the current study and the heterogeneous nature of clinical variables, future experimental investigation of candidate miRNAs would require a model system recapitulating a specific subtype of pediatric HCC. Of note, ToppMiR uses all seven sources of miRNA target predictions, two of which are based on experimentally validated targets 6 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 ; thus, targets identified by ToppMiR may not be from experimentally verified miRNA sources.…”